Prognostic role of bronchial asthma in patients with heart failure.
Mina NakayamaMasaaki KonishiEiichi AkiyamaYukiko MoritaYuma FukutomiNaoki NakayamaTakeshi TakamuraKouichi TamuraKazuo KimuraPublished in: Heart and vessels (2020)
There are few reports investigating the relationship between bronchial asthma (BA) and heart failure (HF). We hypothesized BA may have impact on prognosis in patients with HF. Among 323 consecutive outpatients with HF, 191 patients without chronic obstructive pulmonary disease were analyzed. Twenty patients had BA, most of whom (80.0%) had preserved left ventricular ejection fraction (LVEF ≥ 50%). The use of β-blockers was less frequent (55.0% vs 83.0%. p = 0.01), systolic blood pressure (133 ± 22 vs 120 ± 17 mmHg, p = 0.003), and heart rate (83 ± 14 vs 74 ± 15 bpm, p = 0.02) were higher in patients with BA than those without BA. During median follow up of 24 months, 45 (23.6%) experienced primary outcome defined as a composite of all-cause death, nonfatal myocardial infarction, nonfatal ischemic stroke, and unexpected hospitalization due to HF. Multivariate Cox regression analysis revealed that the presence of BA was independently associated with the occurrence of primary outcome (hazard ratio 3.08, 95% CI 1.42-6.71, p = 0.004). In the subgroup analysis of patients with preserved LVEF, patients with BA exhibited worse outcomes (p = 0.03 by log-rank). Patients with HF complicated by BA, most of whom had preserved LVEF, exhibited worse outcomes than those without BA.
Keyphrases
- ejection fraction
- heart failure
- blood pressure
- left ventricular
- chronic obstructive pulmonary disease
- heart rate
- aortic stenosis
- end stage renal disease
- acute heart failure
- chronic kidney disease
- newly diagnosed
- lung function
- prognostic factors
- heart rate variability
- atrial fibrillation
- risk assessment
- emergency department
- adipose tissue
- clinical trial
- hypertrophic cardiomyopathy
- randomized controlled trial
- skeletal muscle
- cardiac resynchronization therapy
- insulin resistance
- coronary artery disease
- data analysis
- study protocol
- aortic valve
- drug induced